ONWARD Medical Begins EIGER Study With First ARC-IM Implant
Eindhoven, Netherlands, September 3, 2026 ONWARD Medical announced the first implant in the new EIGER clinical feasibility study, evaluating...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Eindhoven, Netherlands, September 3, 2026 ONWARD Medical announced the first implant in the new EIGER clinical feasibility study, evaluating...
LAKE OSWEGO, Ore., July 20, 2026 BIOTRONIK Neuro has unveiled Embrace One® Proactive Intelligence, a proprietary artificial intelligence (AI)...
Bloomington, Minnesota, USA | July 16, 2026 Saluda Medical announced that the U.S. Food and Drug Administration (FDA) has...
GENEVA, Switzerland, July 9, 2026 MindMaze Therapeutics Holding SA has announced its support for a University of Pittsburgh clinical...
MINNEAPOLIS, Minn., July 1, 2026 Saluda Medical has achieved a major regulatory milestone with the U.S. Food and Drug...
